Get the Stockscreener App
11.82
1.37%
-0.1644
Advisorshares Psychedelics Etf stock is traded at $11.82, with a volume of 5,512.
It is down -1.37% in the last 24 hours and up +59.29% over the past month.
See More
Previous Close:
$11.99
Open:
$12.2
24h Volume:
5,512
Relative Volume:
0.23
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.90%
1M Performance:
+59.29%
6M Performance:
-8.35%
1Y Performance:
-20.65%
1-Day Range:
$11.95
$12.20
1-Week Range:
$11.95
$12.62
52-Week Range:
$7.14
$17.00
Advisorshares Psychedelics Etf Stock (PSIL) Company Profile
Name
Advisorshares Psychedelics Etf
Sector
Industry
Phone
-
Address
-
Advisorshares Psychedelics Etf Stock (PSIL) Latest News
5 Best-Performing ETFs of October - Nasdaq
(PSIL) Trading Signals - Stock Traders Daily
Trackinsight ETF data from 14th to 18th October, 2024 - ETF Express
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - TradingView
Learn to Evaluate (PSIL) using the Charts - Stock Traders Daily
Reverse split for AdvisorShares Psychedelic ETF starts today - Green Market Report
AdvisorShares Announces Reverse Split of ETF - PR Newswire
Cannabis And Psychedelics Industries: Summer's Over, Where Are We? - Benzinga
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 1% - Defense World
VIXY Jumped 7.3% Last Week - Yahoo Finance
Best Psychedelic ETFs - Benzinga
Time for Healthcare ETFs? - Yahoo Finance
How to Invest in the Semiconductor Value Chain with These ETFs - The Globe and Mail
Advisorshares Psychedelics ETF (PSIL-A) QuotePress Release - The Globe and Mail
TD Asset Management: The Future of Quantitative Investing - The Globe and Mail
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading 0.9% Higher - Defense World
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - Markets Insider
AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Holdings Increased by Spire Wealth Management - Defense World
Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD - BNN Bloomberg
ETF Issuer: Bristol Gate Capital Partners Inc. - The Globe and Mail
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
A New Horizon: Horizons ETF Management Canada to rebrand as Global X - The Globe and Mail
LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’ - Bloomberg
Mental Health Mavericks: 3 Stocks Changing the Game - Yahoo Finance
Viridian Capital finds psychedelic stocks typically trade at 3x book - Green Market Report
Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha
Psychedelics Are Going Mainstream. Investing in Them Hasn’t. - The Wall Street Journal
11 Most Promising Psychedelic Stocks According to Hedge Funds - Yahoo Finance
MAPS PBC submits first-ever NDA for MDMA-assisted PTSD therapy - Proactive Investors UK
New Report Predicts Psychedelic Industry Shakeout - Green Market Report
Will Psychedelics Companies Win The Mental Health Boom? - Finimize
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Benzinga
How to Invest in Psychedelics - Investing News Network
'We’re in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make payroll - Fortune
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More - Benzinga
Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More - Benzinga
AdvisorShares' Noah Hamman: "It Could Be a Rough, Rough Year" - Nasdaq
PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route (NYSEARCA:PSIL) - Seeking Alpha
Options Listed for the AdvisorShares MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire
The 7 Most Promising Psychedelic Stocks to Buy in February - InvestorPlace
Psychedelics in the Public Markets: 2022 - Psychedelic Alpha
Worst Performing ETFs of 2022 - etf.com
Math Over Myth: Positive Technical Divergences in the Psychedelic Sector - Psychedelic Spotlight
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 - Psychedelic Spotlight
Psychedelic Stocks: ARK Invest and the Reverse Midas Touch - Psychedelic Spotlight
7 Psychedelics Stocks to Buy for a Big Drug Boom - Yahoo Finance
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire
The Growth Potential Of Psychedelics Stocks And ETFs - Seeking Alpha
The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight
Understanding 3 Risks of Investing in Psychedelic Stocks - Psychedelic Spotlight
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Advisorshares Psychedelics Etf Stock (PSIL) Financials Data
There is no financial data for Advisorshares Psychedelics Etf (PSIL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):